H.B. Fuller (FUL) Aktienübersicht
Die H.B. Fuller Company und ihre Tochtergesellschaften formulieren, produzieren und vermarkten Klebstoffe, Dichtstoffe, Beschichtungen, Polymere, Klebebänder, Verkapselungsmaterialien, Additive und andere chemische Spezialprodukte. Mehr Details
| Schneeflocken-Punktzahl | |
|---|---|
| Bewertung | 2/6 |
| Künftiges Wachstum | 1/6 |
| Vergangene Leistung | 4/6 |
| Finanzielle Gesundheit | 3/6 |
| Dividenden | 5/6 |
Belohnungen
Risikoanalyse
FUL Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
Analyst Price Targets
H.B. Fuller Company Wettbewerber
Preisentwicklung & Leistung
| Historische Aktienkurse | |
|---|---|
| Aktueller Aktienkurs | US$63.72 |
| 52-Wochen-Hoch | US$68.63 |
| 52-Wochen-Tief | US$48.71 |
| Beta | 0.96 |
| 1 Monat Veränderung | 9.75% |
| 3 Monate Veränderung | 22.42% |
| 1 Jahr Veränderung | 18.70% |
| 3 Jahre Veränderung | -1.51% |
| 5 Jahre Veränderung | -4.17% |
| Veränderung seit IPO | 2,525.37% |
Aktuelle Nachrichten und Updates
Seeking Alpha • 15h
H.B. Fuller: Margin Growth Looks Unsustainable
Summary H.B. Fuller is rated a sell due to persistent revenue declines, cost inflation, and acquisition risks despite margin improvements. FUL's topline continues to shrink as price hikes fail to offset volume declines; margin gains are driven by transient cost synergies and divestitures. The proposed $800M AMS acquisition risks over-leveraging FUL’s balance sheet, drawing activist pushback and raising medium-term risk. FUL trades at a sales multiple of 1, below the sector median, reflecting weak growth and uncertain outlook if topline recovery fails. Read the full article on Seeking Alpha
Narrativ-Update • Jun 02
FUL: Proposed Medical Solutions Deal Will Shape Long Term Outlook
Analysts kept their fair value estimate for H.B. Fuller steady at $70.43 while adjusting assumptions such as the discount rate and long-term growth. This reflected mixed recent price target moves as firms reassessed the stock around potential corporate actions and valuation.Recent updates
Seeking Alpha • 15h
H.B. Fuller: Margin Growth Looks Unsustainable
Summary H.B. Fuller is rated a sell due to persistent revenue declines, cost inflation, and acquisition risks despite margin improvements. FUL's topline continues to shrink as price hikes fail to offset volume declines; margin gains are driven by transient cost synergies and divestitures. The proposed $800M AMS acquisition risks over-leveraging FUL’s balance sheet, drawing activist pushback and raising medium-term risk. FUL trades at a sales multiple of 1, below the sector median, reflecting weak growth and uncertain outlook if topline recovery fails. Read the full article on Seeking AlphaNarrativ-Update • Jun 02
FUL: Proposed Medical Solutions Deal Will Shape Long Term Outlook
Analysts kept their fair value estimate for H.B. Fuller steady at $70.43 while adjusting assumptions such as the discount rate and long-term growth. This reflected mixed recent price target moves as firms reassessed the stock around potential corporate actions and valuation.Narrativ-Update • Apr 26
FUL: Raised Guidance And P/E Assumptions Will Support Stronger Long Term Outlook
Analysts have adjusted their outlook on H.B. Fuller, with offsetting moves such as a $3 increase in the price target at Citi and a $3 reduction at UBS. These changes are framed around updated views on valuation inputs such as the discount rate and the assumed future P/E multiple.Narrativ-Update • Apr 12
FUL: Long Term Assumptions Will Support Balanced Outlook Despite Mixed Guidance
The analyst price target for H.B. Fuller edges slightly lower to about $70.43 from roughly $70.71, as analysts balance recent target increases from several firms with more cautious revisions tied to adjusted growth, margin, and P/E assumptions. Analyst Commentary Recent Street research on H.B. Fuller presents a mixed picture, with several firms adjusting price targets both higher and lower over the past few months.Narrativ-Update • Mar 29
FUL: Higher Long Term Assumptions Will Support Upside Despite Mixed Guidance
Analysts trimmed the average H.B. Fuller price target by about $1 to $70.71, reflecting a mix of recent upward and downward revisions as they reassessed assumptions on growth, profitability, and valuation multiples. Analyst Commentary Recent research on H.B. Fuller features a mix of higher and lower price targets.Narrativ-Update • Mar 14
FUL: Higher P/E Assumptions Will Support Upside Despite Muted Revenue Outlook
Analysts have lifted their consolidated price target on H.B. Fuller by several dollars, with recent $2 to $6 upward revisions tied to their updated views on the company’s earnings power and P/E assumptions. Analyst Commentary Bullish analysts raising their targets by $2 to $6 are largely reacting to updated assumptions on H.B. Fuller’s earnings power and the P/E they are willing to apply to those earnings.Narrativ-Update • Feb 28
FUL: Free Cash Flow Support Will Offset Modest Outlook And Future P/E Assumptions
H.B. Fuller’s analyst price target has been lifted by several firms, with recent increases of $2 to $6 reflecting analysts’ updated views on its earnings profile and modest adjustments to assumptions such as discount rate, long-term revenue growth, profit margin, and future P/E. Analyst Commentary Recent Street research points to a cluster of higher price targets for H.B. Fuller, with adjustments in the range of $2 to $6.Narrativ-Update • Feb 14
FUL: Free Cash Flow Support Will Balance Organic Headwinds And Future P/E Expectations
The Street has nudged its view on H.B. Fuller higher, with analysts lifting price targets by $2 to $6 as they point to a mix of free cash flow support and valuation considerations, even as they flag near term organic growth headwinds. Analyst Commentary Recent Street research clusters around a common theme for H.B. Fuller, with price target increases framed against ongoing pressure on near term organic growth.Narrativ-Update • Jan 31
FUL: Free Cash Flow Support Will Underpin Higher Future P/E Expectations
Analysts have lifted their price targets on H.B. Fuller by between $2 and $6, citing updated views on valuation, free cash flow support, and a slightly higher assumed future P/E multiple in their models. Analyst Commentary Recent research updates show a cluster of higher price targets for H.B. Fuller, with several firms revisiting their models to reflect revised valuation assumptions, free cash flow support, and modestly higher assumed future P/E multiples.Narrativ-Update • Jan 17
FUL: Higher P/E Expectations Will Shape Medium Term Earnings Power
Analysts have raised their price targets for H.B. Fuller, reflected in the fair value estimate increasing from $68.83 to $71.71. This change is based on a higher assumed future P/E multiple, along with slightly revised assumptions for the discount rate, revenue growth, and profit margins.Analyseartikel • Jan 08
Investors Will Want H.B. Fuller's (NYSE:FUL) Growth In ROCE To Persist
What are the early trends we should look for to identify a stock that could multiply in value over the long term...Analyseartikel • Nov 14
We Think H.B. Fuller (NYSE:FUL) Is Taking Some Risk With Its Debt
The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...Analyseartikel • Oct 03
There May Be Reason For Hope In H.B. Fuller's (NYSE:FUL) Disappointing Earnings
Soft earnings didn't appear to concern H.B. Fuller Company's ( NYSE:FUL ) shareholders over the last week. Our analysis...Analyseartikel • Sep 30
H.B. Fuller Company Beat Analyst Estimates: See What The Consensus Is Forecasting For Next Year
Shareholders might have noticed that H.B. Fuller Company ( NYSE:FUL ) filed its quarterly result this time last week...Narrativ-Update • Sep 28
ND Industries Integration And HHC Pricing Will Secure Stability
Analysts have raised H.B. Fuller's price target to $68.83, citing confidence in continued EBITDA growth, margin expansion, and operational execution despite a weak growth environment. Analyst Commentary Bullish analysts highlight solid year-over-year EBITDA growth expected in fiscal 2025, despite a sluggish growth environment.Analyseartikel • Aug 30
Estimating The Intrinsic Value Of H.B. Fuller Company (NYSE:FUL)
Key Insights Using the 2 Stage Free Cash Flow to Equity, H.B. Fuller fair value estimate is US$53.78 With US$61.05...Analyseartikel • Aug 14
H.B. Fuller Company's (NYSE:FUL) P/E Is On The Mark
H.B. Fuller Company's ( NYSE:FUL ) price-to-earnings (or "P/E") ratio of 31.7x might make it look like a strong sell...Analyseartikel • Jul 30
Is Now The Time To Look At Buying H.B. Fuller Company (NYSE:FUL)?
While H.B. Fuller Company ( NYSE:FUL ) might not have the largest market cap around , it saw a double-digit share price...Analyseartikel • Jul 15
There's Been No Shortage Of Growth Recently For H.B. Fuller's (NYSE:FUL) Returns On Capital
If you're looking for a multi-bagger, there's a few things to keep an eye out for. Ideally, a business will show two...Analyseartikel • May 22
Is H.B. Fuller Company (NYSE:FUL) Worth US$54.7 Based On Its Intrinsic Value?
Key Insights Using the 2 Stage Free Cash Flow to Equity, H.B. Fuller fair value estimate is US$41.64 H.B. Fuller is...Analyseartikel • May 07
H.B. Fuller (NYSE:FUL) Takes On Some Risk With Its Use Of Debt
Warren Buffett famously said, 'Volatility is far from synonymous with risk.' It's only natural to consider a company's...Analyseartikel • Apr 19
H.B. Fuller (NYSE:FUL) Will Pay A Larger Dividend Than Last Year At $0.235
The board of H.B. Fuller Company ( NYSE:FUL ) has announced that it will be increasing its dividend by 5.6% on the 13th...Analyseartikel • Apr 10
Here's What To Make Of H.B. Fuller's (NYSE:FUL) Decelerating Rates Of Return
If you're looking for a multi-bagger, there's a few things to keep an eye out for. In a perfect world, we'd like to see...Analyseartikel • Mar 13
Shareholders Should Be Pleased With H.B. Fuller Company's (NYSE:FUL) Price
With a price-to-earnings (or "P/E") ratio of 22.4x H.B. Fuller Company ( NYSE:FUL ) may be sending bearish signals at...Analyseartikel • Feb 21
What Is H.B. Fuller Company's (NYSE:FUL) Share Price Doing?
H.B. Fuller Company ( NYSE:FUL ), is not the largest company out there, but it saw significant share price movement...Analyseartikel • Jan 23
We Think You Can Look Beyond H.B. Fuller's (NYSE:FUL) Lackluster Earnings
Shareholders appeared unconcerned with H.B. Fuller Company's ( NYSE:FUL ) lackluster earnings report last week. We...Seeking Alpha • Jan 17
Evaluation Of H.B. Fuller After A 30% Decline
Summary H.B. Fuller missed analysts' estimates for the second consecutive quarter, leading to a 3% stock decline and hitting a nearly 3-year low. Despite recent stagnation, H.B. Fuller expects to realize price hikes in 2025, with projected earnings per share growth of 5% and potential for significant future gains. The stock's sharp 30% decline is attributed to its initially high valuation; it now trades at a more reasonable 15.0x forward P/E ratio. Given its cyclical nature, H.B. Fuller offers substantial upside potential but is not a long-term hold; investors should reassess at $79 target. Read the full article on Seeking AlphaAnalyseartikel • Dec 21
Does H.B. Fuller (NYSE:FUL) Have A Healthy Balance Sheet?
Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...Seeking Alpha • Dec 08
H.B. Fuller: Still Not Fully Onboard
Summary H.B. Fuller faces lackluster revenue growth and margin pressure despite M&A activities, leading to cautious investment sentiment and a neutral stance. The company has a long heritage, generating $3.5 billion in 2023 sales, but inventory de-stocking and soft trends have weighed on sales growth for a while. Recent acquisitions and reorganization efforts have increased net debt to $2 billion, raising leverage ratios to 3.2-3.3 times amidst flat organic sales. I remain cautious and seek an entry point in the mid-sixties, given the current 18 times earnings multiple and expensive portfolio reshuffling. Read the full article on Seeking AlphaAnalyseartikel • Dec 07
Earnings Not Telling The Story For H.B. Fuller Company (NYSE:FUL)
With a price-to-earnings (or "P/E") ratio of 22.6x H.B. Fuller Company ( NYSE:FUL ) may be sending bearish signals at...Analyseartikel • Nov 20
Should You Investigate H.B. Fuller Company (NYSE:FUL) At US$73.70?
H.B. Fuller Company ( NYSE:FUL ), is not the largest company out there, but it saw significant share price movement...Analyseartikel • Nov 07
A Look At The Intrinsic Value Of H.B. Fuller Company (NYSE:FUL)
Key Insights Using the 2 Stage Free Cash Flow to Equity, H.B. Fuller fair value estimate is US$92.46 With US$79.33...Aktionärsrenditen
| FUL | US Chemicals | US Markt | |
|---|---|---|---|
| 7D | 2.7% | 1.7% | 2.3% |
| 1Y | 18.7% | 8.8% | 25.5% |
Rendite im Vergleich zur Industrie: FUL übertraf die Branche US Chemicals , die im vergangenen Jahr eine Rendite von 8.8 erzielte.
Rendite vs. Markt: FUL hinter dem Markt US zurück, der im vergangenen Jahr eine Rendite von 25.5 erzielte.
Preisvolatilität
| FUL volatility | |
|---|---|
| FUL Average Weekly Movement | 6.1% |
| Chemicals Industry Average Movement | 6.9% |
| Market Average Movement | 7.2% |
| 10% most volatile stocks in US Market | 16.8% |
| 10% least volatile stocks in US Market | 3.1% |
Stabiler Aktienkurs: FUL hatte in den letzten 3 Monaten im Vergleich zum US -Markt keine signifikante Preisvolatilität.
Volatilität im Zeitverlauf: FULDie wöchentliche Volatilität (6%) ist im vergangenen Jahr stabil geblieben.
Über das Unternehmen
| Gegründet | Mitarbeiter | CEO | Website |
|---|---|---|---|
| 1887 | 7,100 | Celeste Mastin | www.hbfuller.com |
Die H.B. Fuller Company und ihre Tochtergesellschaften formulieren, produzieren und vermarkten Klebstoffe, Dichtstoffe, Beschichtungen, Polymere, Klebebänder, Verkapselungen, Additive und andere chemische Spezialprodukte. Das Unternehmen ist in drei Segmenten tätig: Hygiene-, Gesundheits- und Verbrauchsklebstoffe, Konstruktionsklebstoffe und Bauklebstofflösungen. Das Segment Hygiene-, Gesundheits- und Verbrauchsklebstoffe produziert und liefert industrielle Spezialklebstoffe wie thermoplastische, duroplastische, reaktive, wasserbasierte und lösungsmittelbasierte Produkte für Anwendungen in verschiedenen Märkten wie Verpackung, Verarbeitung, Nonwoven und Hygiene sowie Medizin und Schönheit.
H.B. Fuller Company's Grundlagenzusammenfassung
| FUL grundlegende Statistiken | |
|---|---|
| Marktanteil | US$3.51b |
| Gewinn(TTM) | US$159.76m |
| Umsatz(TTM) | US$3.46b |
21.7x
Kurs-Gewinn-Verhältnis 1.0x
Kurs-Umsatz-VerhältnisIst FUL zu teuer?
Siehe Fair Value und BewertungsanalyseErträge & Einnahmen
| FUL Gewinn- und Verlustrechnung (TTM) | |
|---|---|
| Einnahmen | US$3.46b |
| Kosten der Einnahmen | US$2.35b |
| Bruttogewinn | US$1.10b |
| Sonstige Ausgaben | US$941.96m |
| Gewinn | US$159.76m |
Zuletzt gemeldete Gewinne
Feb 28, 2026
Datum des nächsten Gewinnberichts
Jun 24, 2026
| Gewinn per Aktie (EPS) | 2.93 |
| Bruttomarge | 31.88% |
| Nettogewinnspanne | 4.62% |
| Schulden/Eigenkapital-Verhältnis | 107.9% |
Wie hat sich FUL auf lange Sicht entwickelt?
Historische Performance und VergleicheDividenden
1.5%
Aktuelle Dividendenrendite32%
AusschüttungsquoteUnternehmensanalyse und Finanzdaten Status
| Daten | Zuletzt aktualisiert (UTC-Zeit) |
|---|---|
| Unternehmensanalyse | 2026/06/16 08:47 |
| Aktienkurs zum Tagesende | 2026/06/16 00:00 |
| Gewinne | 2026/02/28 |
| Jährliche Einnahmen | 2025/11/29 |
Datenquellen
Die in unserer Unternehmensanalyse verwendeten Daten stammen von S&P Global Market Intelligence LLC. Die folgenden Daten werden in unserem Analysemodell verwendet, um diesen Bericht zu erstellen. Die Daten sind normalisiert, was zu einer Verzögerung bei der Verfügbarkeit der Quelle führen kann.
| Paket | Daten | Zeitrahmen | Beispiel US-Quelle * |
|---|---|---|---|
| Finanzdaten des Unternehmens | 10 Jahre |
| |
| Konsensschätzungen der Analysten | +3 Jahre |
|
|
| Marktpreise | 30 Jahre |
| |
| Eigentümerschaft | 10 Jahre |
| |
| Verwaltung | 10 Jahre |
| |
| Wichtige Entwicklungen | 10 Jahre |
|
* Beispiel für US-Wertpapiere, für nicht-US-amerikanische Wertpapiere werden gleichwertige regulatorische Formulare und Quellen verwendet.
Sofern nicht anders angegeben, beziehen sich alle Finanzdaten auf einen Jahreszeitraum, werden aber vierteljährlich aktualisiert. Dies wird als Trailing Twelve Month (TTM) oder Last Twelve Month (LTM) Daten bezeichnet. Erfahren Sie mehr.
Analysemodell und Schneeflocke
Einzelheiten zu dem Analysemodell, mit dem dieser Bericht erstellt wurde, finden Sie auf unserer Github-Seite. Außerdem bieten wir Leitfäden zur Verwendung unserer Berichte und Tutorials auf YouTube an.
Erfahren Sie mehr über das Weltklasse-Team, das das Simply Wall St-Analysemodell entworfen und entwickelt hat.
Metriken für Industrie und Sektor
Unsere Branchen- und Sektionskennzahlen werden alle 6 Stunden von Simply Wall St berechnet. Details zu unserem Verfahren finden Sie auf Github.
Analysten-Quellen
H.B. Fuller Company wird von 12 Analysten beobachtet. 7 dieser Analysten hat die Umsatz- oder Gewinnschätzungen übermittelt, die als Grundlage für unseren Bericht dienen. Die von den Analysten übermittelten Daten werden im Laufe des Tages aktualisiert.
| Analyst | Einrichtung |
|---|---|
| Ghansham Panjabi | Baird |
| Paretosh Misra | Berenberg |
| Patrick Cunningham | Citigroup Inc |